# FDA Inspection 1014135 - Gipsco Investment Corp - June 09, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/gipsco-investment-corp/57dc9d90-8c35-46db-87a3-fb02627c88d9
Source feed: FDA_Inspections

> FDA Inspection 1014135 for Gipsco Investment Corp on June 09, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014135
- Company Name: Gipsco Investment Corp
- Inspection Date: 2017-06-09
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1177788 - 2022-07-22](https://www.globalkeysolutions.net/records/fda_inspections/gipsco-investment-corp/72d486e0-a1d6-4e36-a407-eac777716eb1)
- [FDA Inspection 1103566 - 2019-08-29](https://www.globalkeysolutions.net/records/fda_inspections/gipsco-investment-corp/71b320cb-6f3f-4a06-b0f8-acd837844558)

Company: https://www.globalkeysolutions.net/companies/gipsco-investment-corp/29265f19-8c03-46da-97aa-fd3ea30c57a9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c